Cargando…

The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis

BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhadian, Negin, Karami Matin, Behzad, Farnia, Vahid, Zamanian, Mohammad Hossein, Najafi, Farid, Farhadian, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832672/
https://www.ncbi.nlm.nih.gov/pubmed/35144631
http://dx.doi.org/10.1186/s13011-022-00439-5
_version_ 1784648772394942464
author Farhadian, Negin
Karami Matin, Behzad
Farnia, Vahid
Zamanian, Mohammad Hossein
Najafi, Farid
Farhadian, Maryam
author_facet Farhadian, Negin
Karami Matin, Behzad
Farnia, Vahid
Zamanian, Mohammad Hossein
Najafi, Farid
Farhadian, Maryam
author_sort Farhadian, Negin
collection PubMed
description BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healthcare costs and is associated with high morbidity/mortality rates. Early detection of HIV among PWID is essential to prevent and control the spread of the disease. OBJECTIVES: This study aimed to determine the prevalence of PWID among those with late presentation (LP). METHODS: Three electronic databases of PubMed, Scopus, and Web of science were searched using appropriate keywords. Besides the prevalence data reported for PWID among LP, the other outcomes of interest were LP defined as having CD4 count < 350 cells/μL or HIV or advanced disease defined with CD4 count < 200 cells/μL or HIV at the time of diagnosis. RESULTS: Of the 160 studies found, only eight met the inclusion criteria. Among those presented late, 36.5% were PWID (95% CI = 24.88–48.17). Compared with men who have sex with men (MSM), HIV-infected PWID had a higher risk of LP [OR = 1.51; 95% CI = 0.96–2.06]. CONCLUSION: The results of this study show that HIV is diagnosed late in the majority of PWID when CD4 is less than 350 cells/μL. Targeted interventions/strategies are highly required to reduce LP among HIV-infected PWID.
format Online
Article
Text
id pubmed-8832672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88326722022-02-11 The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis Farhadian, Negin Karami Matin, Behzad Farnia, Vahid Zamanian, Mohammad Hossein Najafi, Farid Farhadian, Maryam Subst Abuse Treat Prev Policy Research BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healthcare costs and is associated with high morbidity/mortality rates. Early detection of HIV among PWID is essential to prevent and control the spread of the disease. OBJECTIVES: This study aimed to determine the prevalence of PWID among those with late presentation (LP). METHODS: Three electronic databases of PubMed, Scopus, and Web of science were searched using appropriate keywords. Besides the prevalence data reported for PWID among LP, the other outcomes of interest were LP defined as having CD4 count < 350 cells/μL or HIV or advanced disease defined with CD4 count < 200 cells/μL or HIV at the time of diagnosis. RESULTS: Of the 160 studies found, only eight met the inclusion criteria. Among those presented late, 36.5% were PWID (95% CI = 24.88–48.17). Compared with men who have sex with men (MSM), HIV-infected PWID had a higher risk of LP [OR = 1.51; 95% CI = 0.96–2.06]. CONCLUSION: The results of this study show that HIV is diagnosed late in the majority of PWID when CD4 is less than 350 cells/μL. Targeted interventions/strategies are highly required to reduce LP among HIV-infected PWID. BioMed Central 2022-02-10 /pmc/articles/PMC8832672/ /pubmed/35144631 http://dx.doi.org/10.1186/s13011-022-00439-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Farhadian, Negin
Karami Matin, Behzad
Farnia, Vahid
Zamanian, Mohammad Hossein
Najafi, Farid
Farhadian, Maryam
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title_full The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title_fullStr The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title_full_unstemmed The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title_short The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
title_sort prevalence of people who inject drugs among those with hiv late presentation: a meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832672/
https://www.ncbi.nlm.nih.gov/pubmed/35144631
http://dx.doi.org/10.1186/s13011-022-00439-5
work_keys_str_mv AT farhadiannegin theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT karamimatinbehzad theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT farniavahid theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT zamanianmohammadhossein theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT najafifarid theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT farhadianmaryam theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT farhadiannegin prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT karamimatinbehzad prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT farniavahid prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT zamanianmohammadhossein prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT najafifarid prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis
AT farhadianmaryam prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis